Remembering Dr. Craig Leonardi
The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.
Thursday, October 29, 2026
2026 IPC Psoriasis Masterclass – Europe
Tuesdays, May 12 - June 9, 2026 | Virtual
17:00 - 19:00 CEST
Program Overview
Application
Course Description
Agenda
Faculty
Program Overview
Welcome to the IPC Virtual Psoriasis Masterclass for Europe, an exclusive educational opportunity for early- to mid-career dermatologists and final-year residents actively managing and treating psoriasis. Focusing on fostering a small-group environment, this FREE program offers an intimate, personalized learning experience, ensuring each participant receives the utmost attention and support.
Over the five weekly two-hour sessions of the course, IPC’s world-renowned experts will cover various topics, including the pathogenesis of psoriasis, new and emerging therapies, and how to advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions, and question-and-answer sessions, attendees will gain practical, important information for their clinical practice.
Application
The Masterclass is limited to 60 participants, selected from those dedicated to advancing their expertise in managing and treating psoriasis. If you are a Dermatologist or a final-year resident from Europe with a solid background in dermatology, this program is designed for you.
Thank you for your interest in attending the upcoming masterclass. Registration is now closed. If you would like to register for the class, please email masterclass@psoriasiscouncil.org.
Course Description
Brief Summary of the Course
The IPC Psoriasis Masterclass for Europe is a 10-hour intensive educational program designed for early- to mid-career dermatologists and final-year residents interested in specializing in psoriasis care. With a focus on fostering a small group environment, the Masterclass provides a personalized learning experience, empowering participants to excel in their careers and become leaders in the field of psoriasis.
The agenda has been carefully designed to ensure participants gain the skills and knowledge required to manage patients effectively. Participants will engage in dynamic discussions, interactive Q&A sessions, and invaluable networking opportunities with distinguished experts in the field.
Learning Outcomes
- Understand psoriasis as both a dermatologic and systemic inflammatory disease.
- Develop practical, evidence-based skills for assessing and treating psoriasis across disease severities and patient populations.
- Apply multidisciplinary, case-based clinical decision-making to manage challenging psoriasis cases.
Topics Covered
- Clinical features, phenotypes, and differential diagnosis of psoriasis
- Psoriasis as a systemic inflammatory disease and its major comorbidities
- Management of psoriatic arthritis in dermatology practice
- Metabolic, cardiovascular, and infectious comorbidities
- Treatment approaches: mild disease, phototherapy, conventional systemics, biologics, and when to escalate
- Practical patient assessment: examination, labs, screening, and treatment selection
Prerequisites
The IPC Virtual Psoriasis Masterclass is designed for early- to mid-career dermatologists and final-year residents with a strong foundation in dermatology, who are making treatment decisions and managing patients with psoriasis.
Agenda
Session 1 – Tuesday, May 12 | 17:00-19:00 CEST
EPIDEMIOLOGY AND PATHOGENESIS
WELCOME + INTRODUCTION
Lone Skov, MD, PhD, Denmark
Epidemiology: The Size of the Problem
Juul van der Reek, MD, PhD, Netherlands
Genetic Determinants of Disease
Mari Løset, MD, PhD, Norway
Psoriasis Pathophysiology and Mechanisms
Antonios Kolios, MD, Switzerland
Understanding Patient Goals
Ingvar Ingvarsson, Iceland
Clinical Cases: Shared Decision Making
Malin Assarsson, MD, PhD, Sweden
Closing Comments
Antonios Kolios, MD, Switzerland
Session 2 – Tuesday, May 19 | 17:00-19:00 CEST
CLINICAL PHENOTYPES
WELCOME + INTRODUCTION
Antonios Kolios, MD, Switzerland
Clinical Phenotypes
Brian Kirby, MD, FRCPI, Ireland
Psoriasis in Children
Amy Paller, MS, MD, United States
What’s New in Pustular Psoriasis
Jose-Manuel Carrascosa Carrillo, MD, PhD, Spain
Environmental Disease Triggers and Risk Factors of Disease Onset
Albert Duvetorp, MD, PhD, Sweden
Clinical Cases: Pediatric Psoriasis
Ralph Vighi da Rosa, MSc, MD, Brazil
Closing Comments
Ravi Ramessur, PhD, United Kingdom
Session 3 – Tuesday, May 26 | 17:00-19:00 CEST
MANGEMENT APPROACHES
WELCOME + INTRODUCTION
Ravi Ramessur, PhD, United Kingdom
Topicals: When and How to Use
Peter van de Kerkhof, MD, PhD, Netherlands
Should We Be Integrating Home Phototherapy into Our Psoriasis Care Toolkit?
Cobly Evans, MD, United States
Conventional Systemic Treatment and Small Molecules
Diamant Thaçi, MD, PhD, Germany
Biologics: Where are We Now?
Paolo Gisondi, MD, Italy
Refining Treatment Strategies in Psoriasis
Jonathan Barker, MD, FRCP, United Kingdom
Closing Comments
Lone Skov, MD, PhD, Denmark
Session 4 – Tuesday, June 2 | 17:00-19:00 CEST
COMORBIDITIES
WELCOME + INTRODUCTION
Lone Skov, MD, PhD, Denmark
Psoriasis Arthritis
Anna López Ferrer, MD, PhD, Spain
Psoriasis and Cardiovascular Diseases
Ravi Ramessur, PhD, United Kingdom
Psoriasis and Metabolic Disease, including Liver Disease
Lone Skov, MD, PhD, Denmark
Psoriasis, Infections, and Cancer: What to Do
Zenas Yiu, MSc, MBChB, PhD, MRCP, United Kingdom
Clinical Case: Psoriasis During Pregnancy
Shekhar Neema, MD, India
Closing Comments
Antonios Kolios, MD, Switzerland
Session 5 – Tuesday, June 9 | 17:00-19:00 CEST
THE FUTURE, CHALLENGING CASE PRESENTATIONS AND EXPERT DISCUSSION
WELCOME + INTRODUCTION
Antonios Kolios, MD, Switzerland
AI and Psoriasis
Alexander Navarini, MD, PhD, Switzerland
Challenging Cases – Presented by Delegates
Precision Medicine: What’s Coming Next
Michel Gilliet, MD, Switzerland
Closing Comments
All Chairs
Faculty
Program Co-Chairs
Lone Skov, MD, PhD
Herlev and Gentofte Hospital, University of Copenhagen
Hellerup, Denmark
IPC Board Member
Program Faculty
Jonathan Barker, MD
St John’s Institute of Dermatology, King’s College London
London, United Kingdom
IPC Councilor Emeritus
José-Manuel Carrascosa Carrillo, MD, PhD
University Hospital Germans Trias í Pujol; Autonomous University of Barcelona
Badalona, Spain
IPC Councilor
Mari Løset, MD, PhD
Norwegian University of Science and Technology and St. Olavs Hospital, Trondheim University Hospital
Trondheim, Norway
IPC Councilor
Amy Paller, MS, MD
Northwestern University Feinberg Medical School
Chicago, Illinois, United States
IPC Board Member
Diamant Thaçi, MD, PhD
University of Lübeck, Comprehensive Center for Inflammation Medicine
Lübeck, Germany
IPC Councilor
Peter van de Kerkhof, MD, PhD
International Psoriasis Council
Nijmegen, Netherlands
IPC Chief Medical Officer
This Masterclass is supported in part by:
